Alpha-fetoprotein stimulates leukotriene synthesis in P388D1 macrophages.
Alpha-fetoprotein (AFP) is able to bind specifically polyunsaturated fatty acids, especially arachidonic acid, the major precursor for prostaglandin and leukotriene synthesis. In P388D1 macrophages, AFP was found to reduce prostaglandin synthesis. This reduced synthesis was counter-balanced by a higher release of unmetabolized arachidonic acid and an enhanced production of leukotrienes. The same results were obtained with unactivated and activated cells irrespective of the activator used: lipopolysaccharide, Ca2+ ionophore A23187, phorbol myristate acetate, interferon-gamma, silica, or zymozan particles. The stimulation of leukotriene synthesis by AFP in macrophages thus appears to be a possible mechanism for the in vitro immunosuppressive effects of this oncofetal protein.
D001095:Arachidonic Acids / Q000378:metabolism; D000001:Calcimycin / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007975:Leukotriene B4 / Q000096:biosynthesis*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D013189:SRS-A / Q000096:biosynthesis*; D012822:Silicon Dioxide / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015054:Zymosan / Q000494:pharmacology; D000509:alpha-Fetoproteins / Q000494:pharmacology*
D001095:Arachidonic Acids; D008070:Lipopolysaccharides; D011453:Prostaglandins; D013189:SRS-A; D000509:alpha-Fetoproteins; D007975:Leukotriene B4; D000001:Calcimycin; D012822:Silicon Dioxide; D007371:Interferon-gamma; D015054:Zymosan; D013755:Tetradecanoylphorbol Acetate